Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　– Results of the J-RHYTHM Registry 2

Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　– Results of the J-RHYTHM Registry 2 –

Published:2016 Issue:4 Volume:80 Page:843-851
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kodani Eitaro¹,Atarashi Hirotsugu¹,Inoue Hiroshi²,Okumura Ken³,Yamashita Takeshi⁴,Origasa Hideki⁵,

Affiliation:

1. Department of Internal Medicine and Cardiology, Nippon Medical School, Tama-Nagayama Hospital

2. Saiseikai Toyama Hospital

3. Department of Cardiology, Respiratory Medicine and Nephrology, Hirosaki University Graduate School of Medicine

4. The Cardiovascular Institute

5. Division of Biostatistics and Clinical Epidemiology, University of Toyama

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/4/80_CJ-16-0066/_pdf

Reference35 articles.

1. 1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983–988.

2. 2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995; 155: 469–473.

3. 3. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449–1457.

4. 4. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–867.

5. 5. Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation: The J-RHYTHM Registry study design. J Cardiol 2011; 57: 95–99.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic therapy in cardilogy—systemical improvement of the standard of care for patient population to personalized medicine—;Japanese Journal of Thrombosis and Hemostasis;2023

2. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists;Heart and Vessels;2022-01-21

3. Additional Effects of Antiplatelet Therapy on Anticoagulant Agents in Patients With Bioprosthetic Valves and Atrial Fibrillation;Circulation Journal;2021-12-01

4. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation;Heart and Vessels;2021-11-19

5. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry;Heart and Vessels;2020-11-24